IEEE Trans Biomed Eng. 2022 Dec;69(12):3562-3571. doi: 10.1109/TBME.2022.3171628. Epub 2022 Nov 21.
Embryo vitrification is a fundamental technology utilized in assisted reproduction and fertility preservation. Vitrification involves sequential loading and unloading of cryoprotectants (CPAs) with strict time control, and transferring the embryo in a minimum CPA droplet to the vitrification straw. However, manual operation still cannot effectively avoid embryo loss, and the existing automatic vitrification systems have insufficient system reliability, and operate differently from clinical vitrification protocol. Through collaboration with in vitro fertilization (IVF) clinics, we are in the process realizing a robotic system that can automatically conduct the embryo vitrification process, including the pretreatment with CPAs, transfer of embryo to the vitrification straw, and cryopreservation with liquid nitrogen ( LN). An open microfluidic chip (OMC) was designed to accommodate the embryo during the automatic CPAs pretreatment process. The design of two chambers connected by a capillary gap facilitated solution exchange around the embryo, and simultaneously reduced the risk of embryo loss in the flow field. In accordance to the well-accepted procedure and medical devices in manual operation, we designed the entire vitrification protocol, as well as the robotic prototype. In a practical experiment using mouse embryos, our robotic system showed a 100 % success rate in transferring and vitrifying the embryos, achieved comparable embryo survival rates (90.9 % versus 94.4 %) and development rates (90.0 % versus 94.1 %), when compared with the manual group conducted by the senior embryologist. With this study, we aim to facilitate the standardization of clinical vitrification from manual operation to a more efficient and reliable automated process.
胚胎玻璃化冷冻是辅助生殖和生育力保存中应用的一项基本技术。玻璃化冷冻涉及到严格的时间控制下的抗冻剂(CPAs)的顺序加载和卸载,以及将胚胎转移到最小 CPA 液滴中的玻璃化吸管中。然而,手动操作仍然不能有效地避免胚胎损失,并且现有的自动玻璃化系统系统可靠性不足,与临床玻璃化方案的操作方式不同。通过与体外受精(IVF)诊所合作,我们正在实现一个机器人系统,可以自动进行胚胎玻璃化过程,包括用 CPAs 进行预处理、将胚胎转移到玻璃化吸管中,以及用液氮(LN)进行冷冻保存。设计了一个开放式微流控芯片(OMC),在自动 CPAs 预处理过程中容纳胚胎。两个由毛细间隙连接的腔室的设计促进了胚胎周围溶液的交换,同时降低了流场中胚胎丢失的风险。根据手动操作中公认的程序和医疗器械,我们设计了整个玻璃化方案以及机器人原型。在使用小鼠胚胎的实际实验中,我们的机器人系统在转移和冷冻胚胎方面成功率达到 100%,与由资深胚胎学家进行的手动组相比,胚胎存活率(90.9%对 94.4%)和发育率(90.0%对 94.1%)相当。通过这项研究,我们旨在促进从手动操作到更高效和可靠的自动化过程的临床玻璃化标准化。